A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 14, 2009

Primary Completion Date

June 27, 2012

Study Completion Date

April 1, 2015

Conditions
Melanoma
Interventions
BIOLOGICAL

Immunotherapeutic GSK2132231A

Intramuscular administration

Trial Locations (63)

7

GSK Investigational Site, Dublin

9

GSK Investigational Site, Dublin

10117

GSK Investigational Site, Berlin

13385

GSK Investigational Site, Marseille

19107

GSK Investigational Site, Philadelphia

20141

GSK Investigational Site, Milan

21079

GSK Investigational Site, Dijon

21614

GSK Investigational Site, Buxtehude

23538

GSK Investigational Site, Lübeck

24105

GSK Investigational Site, Kiel

25030

GSK Investigational Site, Besançon

27710

GSK Investigational Site, Durham

28033

GSK Investigational Site, Madrid

29609

GSK Investigational Site, Brest

30625

GSK Investigational Site, Hanover

32806

GSK Investigational Site, Orlando

33612

GSK Investigational Site, Tampa

34295

GSK Investigational Site, Montpellier

34994

GSK Investigational Site, Stuart

35033

GSK Investigational Site, Marburg

35128

GSK Investigational Site, Padua

37044

GSK Investigational Site, Tours

38043

GSK Investigational Site, Grenoble

44093

GSK Investigational Site, Nantes

45122

GSK Investigational Site, Essen

48019

GSK Investigational Site, Ann Arbor

48149

GSK Investigational Site, Münster

50937

GSK Investigational Site, Cologne

53100

GSK Investigational Site, Siena

60637

GSK Investigational Site, Chicago

63110

GSK Investigational Site, St Louis

65191

GSK Investigational Site, Wiesbaden

66421

GSK Investigational Site, Homburg

67063

GSK Investigational Site, Ludwigshafen am Rhein

68167

GSK Investigational Site, Mannheim

69120

GSK Investigational Site, Heidelberg

72076

GSK Investigational Site, Tübingen

75006

GSK Investigational Site, Paris

75018

GSK Investigational Site, Paris

75230

GSK Investigational Site, Dallas

76031

GSK Investigational Site, Rouen

77030

GSK Investigational Site, Houston

80131

GSK Investigational Site, Napoli

90025

GSK Investigational Site, Los Angeles

90095

GSK Investigational Site, Los Angeles

90419

GSK Investigational Site, Nuremberg

92104

GSK Investigational Site, Boulogne

92868

GSK Investigational Site, Orange

97080

GSK Investigational Site, Würzburg

98109

GSK Investigational Site, Seattle

99089

GSK Investigational Site, Erfurt

115478

GSK Investigational Site, Moscow

197758

GSK Investigational Site, Saint Petersburg

07962-1956

GSK Investigational Site, Morristown

06484

GSK Investigational Site, Quedlinburg

07740

GSK Investigational Site, Jena

Unknown

GSK Investigational Site, Cork

Co Galway

GSK Investigational Site, Galway

31-108

GSK Investigational Site, Krakow

10-228

GSK Investigational Site, Olsztyn

61-866

GSK Investigational Site, Poznan

02-781

GSK Investigational Site, Warsaw

08036

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY